Shingrix in Renal Transplant Recipients

Abroad (travel likely)RecruitingPHASE3

Conditions

Kidney Transplant Recipient Response to Shingrix Vaccine · Kidney Failure · Kidney Failure, Chronic · Kidney Transplantation · Herpes Zoster (HZ)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Colorado Anschutz, Aurora, Colorado, United States
Contact: Study coordinator (Tori Rutherford, RN BSN) · tori.rutherford@childrenscolorado.org · 303-724-2454
Emory University, Atlanta, Georgia, United States
Contact: Study coordinator (Varun K Phadke, MD) · varun.phadke@emory.edu
Contact: Principal Investigator (Varun K Phadke, MD)
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Amy C Sherman, MD) · acsherman@bwh.harvard.edu
Contact: Principal Investigator (Amy C Sherman, MD)
Baylor College of Medicine, Houston, Texas, United States
Contact: Study coordinator (Hana ElSahly, MD) · Hana.ElSahly@bcm.edu
Contact: Principal Investigator (Hana ElSahly, MD)

Study leads

Myron J Levin, MD
Principal Investigator
University of Colorado Anschutz School of Medicine

View source on ClinicalTrials.gov